Simplifying Global Compliance
Anti-Anthrax Drug Gets AIDAC Recommendation on Resubmission
Washington Drug Letter
The FDA’s Anti-Infective Drugs Advisory Committee on Nov. 2 recommended approval of GlaxoSmithKline’s (GSK) 40-mg/kg raxibacumab IV solution, with or without an antimicrobial, to treat adults infected in an airborne anthrax attack.
To View This Article:
Buy This Article Now
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing